65 related articles for article (PubMed ID: 38473234)
21. Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling.
Gupta N; Srivastava SK
Mol Cancer Ther; 2019 Oct; 18(10):1708-1720. PubMed ID: 31270151
[TBL] [Abstract][Full Text] [Related]
22. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
23. The role of cellular reactive oxygen species in cancer chemotherapy.
Yang H; Villani RM; Wang H; Simpson MJ; Roberts MS; Tang M; Liang X
J Exp Clin Cancer Res; 2018 Nov; 37(1):266. PubMed ID: 30382874
[TBL] [Abstract][Full Text] [Related]
24. Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
Lea MA; Kim H; desBORDES C
Anticancer Res; 2018 Sep; 38(9):5003-5011. PubMed ID: 30194144
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability.
Barbieri F; Würth R; Pattarozzi A; Verduci I; Mazzola C; Cattaneo MG; Tonelli M; Solari A; Bajetto A; Daga A; Vicentini LM; Mazzanti M; Florio T
Front Pharmacol; 2018; 9():899. PubMed ID: 30186163
[TBL] [Abstract][Full Text] [Related]
26. AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.
Verma K; Gupta N; Zang T; Wangtrakluldee P; Srivastava SK; Penning TM; Trippier PC
Mol Cancer Ther; 2018 Sep; 17(9):1833-1845. PubMed ID: 29891491
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors and Preventions of Breast Cancer.
Sun YS; Zhao Z; Yang ZN; Xu F; Lu HJ; Zhu ZY; Shi W; Jiang J; Yao PP; Zhu HP
Int J Biol Sci; 2017; 13(11):1387-1397. PubMed ID: 29209143
[TBL] [Abstract][Full Text] [Related]
28. The Roles of ROS in Cancer Heterogeneity and Therapy.
de Sá Junior PL; Câmara DAD; Porcacchia AS; Fonseca PMM; Jorge SD; Araldi RP; Ferreira AK
Oxid Med Cell Longev; 2017; 2017():2467940. PubMed ID: 29123614
[TBL] [Abstract][Full Text] [Related]
29. The Role of Oxidative Stress Modulators in Breast Cancer.
Gurer-Orhan H; Ince E; Konyar D; Saso L; Suzen S
Curr Med Chem; 2018; 25(33):4084-4101. PubMed ID: 28699501
[TBL] [Abstract][Full Text] [Related]
30. ROS in Cancer: The Burning Question.
Chio IIC; Tuveson DA
Trends Mol Med; 2017 May; 23(5):411-429. PubMed ID: 28427863
[TBL] [Abstract][Full Text] [Related]
31. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase.
Bridges HR; Sirviö VA; Agip AN; Hirst J
BMC Biol; 2016 Aug; 14():65. PubMed ID: 27506389
[TBL] [Abstract][Full Text] [Related]
32. Anti-malarial Drugs Primaquine and Chloroquine Have Different Sensitization Effects with Anti-mitotic Drugs in Resistant Cancer Cells.
Choi AR; Kim JH; Woo YH; Kim HS; Yoon S
Anticancer Res; 2016 Apr; 36(4):1641-8. PubMed ID: 27069141
[TBL] [Abstract][Full Text] [Related]
33. The role of oxidative stress on breast cancer development and therapy.
Hecht F; Pessoa CF; Gentile LB; Rosenthal D; Carvalho DP; Fortunato RS
Tumour Biol; 2016 Apr; 37(4):4281-91. PubMed ID: 26815507
[TBL] [Abstract][Full Text] [Related]
34. Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication.
Johar R; Sharma R; Kaur A; Mukherjee TK
Anticancer Agents Med Chem; 2015; 16(2):190-9. PubMed ID: 25980816
[TBL] [Abstract][Full Text] [Related]
35. The Repurposing Drugs in Oncology (ReDO) Project.
Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP; Vikas P
Ecancermedicalscience; 2014; 8():442. PubMed ID: 25075216
[TBL] [Abstract][Full Text] [Related]
36. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria.
Bridges HR; Jones AJ; Pollak MN; Hirst J
Biochem J; 2014 Sep; 462(3):475-87. PubMed ID: 25017630
[TBL] [Abstract][Full Text] [Related]
37. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
Kim JH; Choi AR; Kim YK; Yoon S
Biochem Biophys Res Commun; 2013 Nov; 441(3):655-60. PubMed ID: 24284282
[TBL] [Abstract][Full Text] [Related]
38. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.
Ray PD; Huang BW; Tsuji Y
Cell Signal; 2012 May; 24(5):981-90. PubMed ID: 22286106
[TBL] [Abstract][Full Text] [Related]
39. Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells.
Pramanik KC; Boreddy SR; Srivastava SK
PLoS One; 2011; 6(5):e20151. PubMed ID: 21647434
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial complex III defects contribute to inefficient respiration and ATP synthesis in the myocardium of Trypanosoma cruzi-infected mice.
Wen JJ; Garg NJ
Antioxid Redox Signal; 2010 Jan; 12(1):27-37. PubMed ID: 19624257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
